OSTEOSARCOMA METASTATIC
Clinical trials for OSTEOSARCOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new OSTEOSARCOMA METASTATIC trials appear
Sign up with your email to follow new studies for OSTEOSARCOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to slow rare Cancer's spread
Disease control Recruiting nowThis study tests a drug called zanzalintinib (XL092) in 29 people with advanced leiomyosarcoma that has spread or cannot be removed by surgery. The drug works by blocking signals that help cancer cells grow. The goal is to see if it can slow the cancer's progression longer than c…
Matched conditions: OSTEOSARCOMA METASTATIC
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy offers hope for tough bone cancer
Disease control Recruiting nowThis study tests a combination of two drugs, apatinib and liposomal irinotecan, in people with advanced osteosarcoma (bone cancer) that has spread or come back after standard treatments. The goal is to find the safest and most effective dose and see if the combo can shrink tumors…
Matched conditions: OSTEOSARCOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC